← back to search

Laurence Klotz

Sunnybrook Health Science Centre · CA
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Cancer, Lipids, and Metabolism.
h-index
86
citations
34,770
works
825
NIH funding
primary concept
email

Recent publications

Micro-ultrasound for prostate cancer.
2026cited by 1position: contributordoi
Prognostic value of MR visibility/invisibility in men on Active Surveillance.
2025cited by 3position: contributordoi
Should systematic prostatic biopsies be discontinued?
2025cited by 1position: contributordoi
Imaging in focal therapy: advanced ultrasound imaging and mpMRI-a comprehensive review.
2025cited by 0position: contributordoi
Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry
European Urology Oncology 2024cited by 20position: middledoi
Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE).
2024cited by 9position: contributordoi
Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
2024cited by 7position: contributordoi
Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies.
2024cited by 1position: contributordoi
'Spin' in urology non-randomised studies comparing therapeutic interventions: a temporal analysis.
2024cited by 0position: contributordoi
Prognostic value of MR visibility/invisibility in men on Active Surveillance
2024cited by 0position: contributordoi
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer.
2023cited by 3position: contributordoi
Re: MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy
European Urology 2023cited by 0position: contributordoi
Effect of <sup>18</sup>F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
2022cited by 38position: contributordoi
Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.
2022cited by 20position: contributordoi
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy.
2022cited by 5position: contributordoi
Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer
Contemporary Clinical Trials 2021cited by 51position: firstdoi
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus
Urologic Oncology Seminars and Original Investigations 2021cited by 24position: middledoi
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
Human Genetics and Genomics Advances 2021cited by 23position: middledoi
Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients
Urology 2021cited by 11position: middledoi
Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer.
2021cited by 5position: contributordoi
The 'C' Words: parallels and analogies between Prostate Cancer and Covid-19.
2021cited by 1position: contributordoi
Reply by Authors.
2021cited by 0position: contributordoi
Intermediate-risk Prostate Cancer: Stratification and Management
European Urology Oncology 2020cited by 96position: middledoi
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
The Journal of Urology 2020cited by 80position: firstdoi
Active surveillance in intermediate-risk prostate cancer.
2020cited by 62position: contributordoi
Can high resolution micro-ultrasound replace MRI in the diagnosis of prostate cancer?
European Urology Focus 2020cited by 46position: contributordoi
Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines
European Urology Focus 2020cited by 27position: middledoi
Systematic review and meta-analysis of trials evaluating the role of adjuvant radiation after radical prostatectomy for prostate cancer: Implications for early salvage
Canadian Urological Association Journal 2020cited by 9position: middledoi
3:45 PM Abstract No. 341 Pivotal study of magnetic resonance imaging–guided transurethral ultrasound ablation in men with localized prostate cancer: 12-month clinical and imaging outcomes
Journal of Vascular and Interventional Radiology 2020cited by 0position: middledoi
Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project
World Journal of Urology 2019cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 20 papers (2019–2026)Andrew Loblaw · Sunnybrook Health Science Centre4 papers (2014–2025)Lars Egevad · Karolinska Institutet3 papers (2014–2014)Matthew R. Cooperberg · UCSF Helen Diller Family Comprehensive Cancer Center3 papers (2012–2021)Neal D. Shore · Urologic Research Institute3 papers (2014–2021)S. Ghai · Mount Sinai Hospital3 papers (2024–2026) · 3 papers (2019–2025)Rodolfo Montironi · Ospedale Humanitas Gradenigo3 papers (2014–2020)Shahrokh F. Shariat · University Hospital in Motol2 papers (2012–2012)Jean de la Rosette · Guangzhou Medical University2 papers (2020–2025)Mark Emberton · University College London2 papers (2012–2021)Zachary Klaassen · Augusta University2 papers (2020–2021)Gerald L. Andriole · Division of Cancer Epidemiology and Genetics2 papers (2014–2021)Mathieu Burtnyk · Sunnybrook Health Science Centre2 papers (2020–2020)Antonio Finelli · Collaborative Group (United States)2 papers (2013–2022)Christopher J.D. Wallis · Teikyo University2 papers (2020–2021)Michael O. Koch · Indiana University School of Medicine2 papers (2012–2020)Mahul B. Amin · Ontario Institute for Cancer Research2 papers (2014–2014)John R. Srigley · University of Toronto2 papers (2014–2014)Arul M. Chinnaiyan · Bharathidasan University2 papers (2014–2014)